Study Drug

DRUG4 trials

Sponsors

Pfizer, Biogen, Weill Medical College of Cornell University, JW Pharmaceutical

Conditions

HealthyHyperprolactinemiaMetastatic Breast CancerMultiple SclerosisParkinson's Disease

Phase 1

A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults

CompletedNCT02201849

BiogenMultiple Sclerosis

Start: 2014-07-31End: 2014-12-31Updated: 2019-11-26

Single and Multiple Ascending Dose Study of JW1601 for Healthy Volunteers

CompletedNCT04018170

JW PharmaceuticalHealthy

Start: 2019-02-15End: 2019-12-15Updated: 2020-02-13

Phase 2

LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer

TerminatedNCT02538471

Weill Medical College of Cornell UniversityMetastatic Breast Cancer

Start: 2015-08-10End: 2019-02-20Updated: 2019-12-09

Unknown Phase

Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)

CompletedNCT01270711

PfizerHyperprolactinemia, Parkinson's Disease

Start: 2010-11-30End: 2013-02-28Updated: 2014-05-02

Related Papers

New advances in cancer therapy targeting TGF-β signaling pathways

Molecular Therapy — Oncolytics2023-12-0127 citations